Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.
Press releases published on May 23, 2025
California Intercontinental University Celebrates Student Achievement Through Inspiring Webinar on Purpose and Meaning
EIN Presswire
·
May 23, 2025
Raphael Kleinmann’s webinar at CIU explores meaning, leadership, and his book, inspiring students and faculty worldwide. CA, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- California Intercontinental University (CIU) is proud to highlight the …
Bank Indonesia’s Rate Cut Strategy: Navigating Growth, Stability, and BRICS Realities - EBC Financial Group Analyses
EIN Presswire
·
May 23, 2025
EBC Financial Group unpacks BI’s 25 bps cut to 5.50%—weighing fiscal stimulus against rupiah risks and the geopolitical opportunities of BRICS membership JAKARTA, INDONESIA, May 23, 2025 /EINPresswire.com/ -- Bank Indonesia (BI) has lowered its …
Imperial Announces Normal Course Issuer Bid
GlobeNewswire
·
May 23, 2025
VANCOUVER, British Columbia, May 23, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial” or the “Company”) (TSX:III) announces the Toronto Stock Exchange (the “TSX”) has accepted the Company’s Notice of Intention to make a Normal Course Issuer …
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F
GlobeNewswire
·
May 23, 2025
Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, …
Boundless Bio Announces Portfolio Prioritization and Runway Extension
GlobeNewswire
·
May 23, 2025
Portfolio prioritization focuses on novel-novel combination therapy of BBI-355 and BBI-825 and new development candidate, BBI-940, for novel kinesin program Operating runway extended into the first half of 2028, through expected proof-of-concept clinical …
Massive Antimony Bearing Stibnite Reported in Bald Hill Drill Holes
GlobeNewswire
·
May 23, 2025
ROUYN-NORANDA, Quebec, May 23, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …
Forte Minerals Announces Private Placement of up to C$2.4 Million
GlobeNewswire
·
May 23, 2025
“Not for distribution to United States newswire services or for dissemination in the United States.” VANCOUVER, British Columbia, May 23, 2025 (GLOBE NEWSWIRE) -- Forte Minerals Corp. (“Forte” or the “Company”) (CSE: CUAU) (OTCQB: FOMNF) (Frankfurt: 2OA), …
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
May 23, 2025
SOUTH SAN FRANCISCO, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …
Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 23, 2025
SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the Jefferies Global Healthcare Conference, taking place June 3-5, 2025 in New York, NY. Jefferies …
Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas
GlobeNewswire
·
May 23, 2025
WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA® (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice …
Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering
GlobeNewswire
·
May 23, 2025
ISELIN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the pricing of an …
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 23, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, …